A Neonate with Sepsis

Abstract

Get full access to this article

View all access options for this article.

References

1. Yarush LI , Steele RW. Diagnosis and prospective treatment of enteroviral infections in children. Clin Pediatr. 2000;39:209-211.

2. Sawyer MH. Enterovirus infections: diagnosis and treatment. Pediatr Infect Disf 1999;18:1033-1040.

3. Modlin JF , Kinney JS. Perinatal enterovirus infections. Adv Pediatr Infect Dis.1987;2:57-78.

4. Lake AM , Lauer BA , Clark JC , et al. Enterovirus infections in neonates. J Pediatr. 1976;89:787-791.

5. Abzug MJ , Levin MJ , Rotbart HA. Profile of enterovirus disease in the first two weeks of life. Pediatr Infect Dis j 1993;12;820-824.

6. Abzug MJ , Johnson SM. Catastrophic intracranial hemorrhage complicating perinatal viral infections. Pediatr Infect Disj 2000;19:556-565.

7. Tarcan A , Ozbek N , Gurakan B. Bone marrow failure with concurrent enteroviral infection in a newborn. Pediatr Infect Dis J. 2001;20:719-721.

8. Romero JR. Reverse-transcription polymerase chain reaction detection of the enteroviruses: overview and clinical utility in pediatric enteroviral infections. Arch Pathol Lab Med 1999;123:1161-1169.

9. Hamilton MS , Jackson MA , Abel D. Clinical utility of polymerase chain reaction testing for enteroviral meningitis. Pediatr Infect Disj 1999;18:533-538.

10.

10. Byington CL , Taggart BS , Carroll KC , et al. A polymerase chain reactionbased epidemiologic investigation of the incidence of nonpolio enteroviral infections in febrile and afebrile infants 90 days and younger. Pediatrics. 1999;103:656-656.

11.

11. Weiner LB , Rotbart HA , Gilbert DL , et al. Treatment of enterovirus meningitis with pleconaril (VP 63843), an antipicornaviral agent (abstract LB27) In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology; 1997.

12.

12. Schiff GM , Mc Kinlay MA , Sherwood JR. Oral efficacy of VP63843 in coxsackie-virus A21-infacted volunteers (abstract H-43): In: Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, DC: American Society for Microbiology; 1996.

13.

13. Groarke JM , Pevear DC. Attenuated virulence of pleconaril-resistant coxsackievirus B3 variants. J Infect Dis. 1999;179:1538-1542.

14.

14. Mc Kinlay MA , Pevear DC , Rossmann MG. Treatment of the picornavirus common cold by inhibition of viral uncoating and attachment. Annu Rev Microbiol. 1992;46:635-654.